Vertebral Strength Changes as Assessed by Finite Element Analysis

Taro Mawatari; Satoshi Ikemura; Yukihide Iwamoto

doi:10.1007/978-4-431-55778-4_5

Vertebral Strength Changes as Assessed by Finite Element Analysis

Taro Mawatari, Satoshi Ikemura, Yukihide Iwamoto

Orthopedic Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Currently available surrogate markers of osteoporosis including areal bone mineral density (aBMD) measured by dual energy absorptiometry (DXA), bone turnover markers (BTMs), and fracture risk assessment tool (FRAX®) are limited for the use as targets, because those values are not directly reflecting bone strength. Because directly measuring the strength of any bone in a living human subject is not feasible, the combination of finite element analysis (FEA) and clinical computed tomography (CT) is an alternative and powerful technique for noninvasive assessment of whole bone strength. While there are several limitations including the radiation exposure, FEA has the potential to improve clinical assessment of osteoporosis. In this chapter, methodology and recent advances of FEA in this field including treatment efficacy assessment and fracture risk assessment are presented.

Original language	English
Title of host publication	Skeletal Adaptation to Mechanical Strain
Subtitle of host publication	A Key Role in Osteoporosis
Publisher	Springer Japan
Pages	81-99
Number of pages	19
ISBN (Electronic)	9784431557784
ISBN (Print)	9784431557777
DOIs	https://doi.org/10.1007/978-4-431-55778-4_5
Publication status	Published - Jan 1 2015

All Science Journal Classification (ASJC) codes

Medicine(all)

Access to Document

10.1007/978-4-431-55778-4_5

Cite this

@inbook{6d28d496d5c14f858ff615dd72ab4241,

title = "Vertebral Strength Changes as Assessed by Finite Element Analysis",

abstract = "Currently available surrogate markers of osteoporosis including areal bone mineral density (aBMD) measured by dual energy absorptiometry (DXA), bone turnover markers (BTMs), and fracture risk assessment tool (FRAX{\textregistered}) are limited for the use as targets, because those values are not directly reflecting bone strength. Because directly measuring the strength of any bone in a living human subject is not feasible, the combination of finite element analysis (FEA) and clinical computed tomography (CT) is an alternative and powerful technique for noninvasive assessment of whole bone strength. While there are several limitations including the radiation exposure, FEA has the potential to improve clinical assessment of osteoporosis. In this chapter, methodology and recent advances of FEA in this field including treatment efficacy assessment and fracture risk assessment are presented.",

author = "Taro Mawatari and Satoshi Ikemura and Yukihide Iwamoto",

note = "Publisher Copyright: {\textcopyright} Springer Japan 2016.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-4-431-55778-4_5",

language = "English",

isbn = "9784431557777",

pages = "81--99",

booktitle = "Skeletal Adaptation to Mechanical Strain",

publisher = "Springer Japan",

address = "Japan",

}

TY - CHAP

T1 - Vertebral Strength Changes as Assessed by Finite Element Analysis

AU - Mawatari, Taro

AU - Ikemura, Satoshi

AU - Iwamoto, Yukihide

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Currently available surrogate markers of osteoporosis including areal bone mineral density (aBMD) measured by dual energy absorptiometry (DXA), bone turnover markers (BTMs), and fracture risk assessment tool (FRAX®) are limited for the use as targets, because those values are not directly reflecting bone strength. Because directly measuring the strength of any bone in a living human subject is not feasible, the combination of finite element analysis (FEA) and clinical computed tomography (CT) is an alternative and powerful technique for noninvasive assessment of whole bone strength. While there are several limitations including the radiation exposure, FEA has the potential to improve clinical assessment of osteoporosis. In this chapter, methodology and recent advances of FEA in this field including treatment efficacy assessment and fracture risk assessment are presented.

AB - Currently available surrogate markers of osteoporosis including areal bone mineral density (aBMD) measured by dual energy absorptiometry (DXA), bone turnover markers (BTMs), and fracture risk assessment tool (FRAX®) are limited for the use as targets, because those values are not directly reflecting bone strength. Because directly measuring the strength of any bone in a living human subject is not feasible, the combination of finite element analysis (FEA) and clinical computed tomography (CT) is an alternative and powerful technique for noninvasive assessment of whole bone strength. While there are several limitations including the radiation exposure, FEA has the potential to improve clinical assessment of osteoporosis. In this chapter, methodology and recent advances of FEA in this field including treatment efficacy assessment and fracture risk assessment are presented.

UR - http://www.scopus.com/inward/record.url?scp=84956838177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956838177&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-55778-4_5

DO - 10.1007/978-4-431-55778-4_5

M3 - Chapter

AN - SCOPUS:84956838177

SN - 9784431557777

SP - 81

EP - 99

BT - Skeletal Adaptation to Mechanical Strain

PB - Springer Japan

ER -

Vertebral Strength Changes as Assessed by Finite Element Analysis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this